| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H50O6 |
| Molecular Weight | 494.7037 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])COC(=O)[C@@]4([H])C[C@H](O)[C@H](O)C[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)[C@H](O)[C@@H](O)[C@@H](CC)C(C)C
InChI
InChIKey=HJIKODJJEORHMZ-DNVPGCTHSA-N
InChI=1S/C29H50O6/c1-7-17(15(2)3)26(33)25(32)16(4)19-8-9-20-18-14-35-27(34)22-12-23(30)24(31)13-29(22,6)21(18)10-11-28(19,20)5/h15-26,30-33H,7-14H2,1-6H3/t16-,17-,18-,19+,20-,21-,22+,23-,24+,25-,26-,28+,29+/m0/s1
(22S,23S)-homobrassinolide (also known as isohomobrassinolide) is a member of the plant-derived polyhydroxylated derivatives of 5α-cholestane family of compounds; known as brassinosteroids. It was shown that isohomobrassinolide selectively activates the PI3K/Akt signaling pathway by increasing Akt phosphorylation in vitro.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
SUBSTANCE RECORD
